Article Text

Download PDFPDF
20p12.3 microdeletion predisposes to Wolff–Parkinson–White syndrome with variable neurocognitive deficits
  1. S R Lalani1,
  2. J V Thakuria2,
  3. G F Cox2,
  4. X Wang1,
  5. W Bi1,
  6. M S Bray1,
  7. C Shaw1,
  8. S W Cheung1,
  9. A C Chinault1,
  10. B A Boggs1,
  11. Z Ou1,
  12. E K Brundage1,
  13. J R Lupski1,
  14. J Gentile2,
  15. S Waisbren2,
  16. A Pursley1,
  17. L Ma3,
  18. M Khajavi1,
  19. G Zapata1,
  20. R Friedman4,
  21. J J Kim4,
  22. J A Towbin4,
  23. P Stankiewicz1,
  24. S Schnittger5,
  25. I Hansmann6,
  26. T Ai7,
  27. S Sood7,
  28. X H Wehrens7,
  29. J F Martin3,
  30. J W Belmont1,
  31. L Potocki1
  1. 1
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
  2. 2
    Division of Genetics, Children’s Hospital Boston, Boston, Massachusetts, USA
  3. 3
    Institute of Biosciences and Technology, Texas A&M System Health Science Center, Houston, Texas, USA
  4. 4
    Department of Cardiology, Baylor College of Medicine, Houston, Texas, USA
  5. 5
    MLL Munich Leukemia Laboratory, Munich, Germany
  6. 6
    Institut für Humangenetik und Medizinische Biologie, Halle/Saale, Germany
  7. 7
    Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA
  1. Dr S R Lalani, Department of Molecular and Human Genetics, One Baylor Plaza, BCM225, MARB, R713, Houston, Texas 77030, USA; seemal{at}


Background: Wolff–Parkinson–White syndrome (WPW) is a bypass re-entrant tachycardia that results from an abnormal connection between the atria and ventricles. Mutations in PRKAG2 have been described in patients with familial WPW syndrome and hypertrophic cardiomyopathy. Based on the role of bone morphogenetic protein (BMP) signalling in the development of annulus fibrosus in mice, it has been proposed that BMP signalling through the type 1a receptor and other downstream components may play a role in pre-excitation.

Methods and results: Using the array comparative genomic hybridisation (CGH), we identified five individuals with non-recurrent deletions of 20p12.3. Four of these individuals had WPW syndrome with variable dysmorphisms and neurocognitive delay. With the exception of one maternally inherited deletion, all occurred de novo, and the smallest of these harboured a single gene, BMP2. In two individuals with additional features of Alagille syndrome, deletion of both JAG1 and BMP2 were identified. Deletion of this region has not been described as a copy number variant in the Database of Genomic Variants and has not been identified in 13 321 individuals from other cohort examined by array CGH in our laboratory.

Conclusions: Our findings demonstrate a novel genomic disorder characterised by deletion of BMP2 with variable cognitive deficits and dysmorphic features and show that individuals bearing microdeletions in 20p12.3 often present with WPW syndrome.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Funding: This work was supported by the Doris Duke Charitable Foundation and the Gillson Longenbaugh Foundation to SRL and by R01 DE/HD 12324-12 to JFM.

  • Patient consent: Obtained

  • ▸ Additional figures are published online only at